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INTRODUCTION
Seizures may complicate subarachnoid hemorrhage 
(SAH) and can precipitate aneurysmal rebleeding, raise 
intracranial pressure and increase the cerebral metabolic 
demands. Although seizures most often occur early 








Background: Seizures are a recognized complication of subarachnoid hemor-
rhage (SAH). They can increase the cerebral metabolic demands and lead to 
cardiopulmonary compromise. This could be detrimental in the setting of delayed 
cerebral ischemia (DCI), when the brain tissue is vulnerable to further reductions 
in oxygen delivery or increases in demand. An association between seizures and 
worsening ischemia could influence the decision to use antiepileptic drug (AED) 
prophylaxis in patients with vasospasm.
Case Description: A 64-year-old woman developed confusion, aphasia and right 
hemiparesis on day 7 after aneurysmal SAH. Angiography confirmed severe anterior 
circulation vasospasm. She initially responded to hypertensive therapy with almost 
complete resolution of her ischemic neurological deficits. However, on day 10, she 
had a single generalized seizure and required intubation for airway protection. 
Her blood pressure dropped with AED initiation, necessitating an increase in the 
previously stable dose of vasopressors. She developed aphasia and worsening 
hemiparesis that did not resolve despite hemodynamic augmentation. Subsequent 
head computed tomographies revealed new infarction in the left anterior cerebral 
artery territory not present previously. She had received prophylactic phenytoin 
for only 3 days, as per our SAH protocol.
Conclusion: AED prophylaxis is typically used early after SAH when the risk is 
high and a seizure may precipitate aneurysmal rebleeding. This case illustrates 
how a later seizure in the setting of vasospasm can lead to decompensation of 
DCI, with potential for irreversible infarction. Therefore, patients with vasospasm 
may benefit from extended durations of prophylaxis to prevent such complications.
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after SAH, even prior to hospitalization, patients remain 
at increased risk throughout their hospital course.[6] 
While recent guidelines support the use of antiepileptic 
drugs (AEDs) for seizure prophylaxis after SAH,[1] they 
specifically recommend against long-term administration, 
as greater AED exposure has been linked to worse 
outcome.[5,7] Many institutions, including ours, have 
now adopted a brief regimen of AED prophylaxis after 
SAH; one concern regarding this change is that it does 
not provide coverage during the period when patients 
are at the highest risk for delayed cerebral ischemia. We 
present the case of a patient with SAH and clinically 
stable vasospasm, no longer on AED prophylaxis, who 
developed cerebral infarction and irreversible neurological 
deficits after an isolated seizure.
CASE REPORT
A 64-year-old woman with a history of rheumatoid arthritis 
was diagnosed with SAH based on head computed 
tomography (CT) after presenting with headache 
and nausea. The initial neurological examination was 
normal, but she subsequently developed lethargy due 
to worsening hydrocephalus, which reversed after a 
ventriculostomy was placed. Cerebral angiogram revealed 
a 2.5-mm anterior communicating artery aneurysm that 
was coiled successfully on day 2 post-SAH. On admission, 
the patient was loaded with phenytoin (Dilantin) for 
seizure prophylaxis, and this was continued for the first 
3 days of her hospital stay. She remained neurologically 
stable for the first 6 days of her hospitalization.
On day 7, she developed aphasia with perseveration, 
dysnomia and disorientation. She also manifested new 
motor deficits, with right facial weakness and dense right 
hemiparesis. The head CT was unchanged. Hemodynamic 
augmentation was immediately initiated, including 
increased fluid administration and the blood pressure 
titrated up until a clinical response was noted (mean 
arterial pressure [MAP] was increased to 110 and then 
120–130 mmHg using phenylephrine). An angiogram 
confirmed severe vasospasm involving the left anterior 
cerebral artery, which was treated with intra-arterial 
nicardipine. There was also mild to moderate vasospasm 
involving the right anterior and bilateral middle 
cerebral arteries (MCA). Immediately post-procedure, 
she had persistent dense hemiparesis and aphasia post-
procedurally. MAP was further increased and she received 
a transfusion of packed red blood cells for hemoglobin of 
8 g/dl. With maximal hemodynamic therapy (target MAP 
140–150 mmHg), her deficits improved with minimal 
residual facial weakness, antigravity movement on the 
right side and improved naming. Head CT on day 8 
revealed a small new hypodense lesion in the left MCA 
territory, but this was otherwise unchanged.
She continued on stable doses of vasopressors with 
further improvement in her neurological status. By 
day 10, she was fully oriented, minimally aphasic and 
had only pronator drift on the right side. However, 
later that evening, she had a brief tonic–clonic seizure 
associated with decreased mental status, for which she 
was intubated. She received a 2-mg dose of lorazepam 
(Ativan), after which her blood pressure fell to MAPs of 
60–70s mmHg for approximately 15 min, necessitating 
a transient increase in vasopressor requirements. She 
was subsequently loaded with Fosphenytoin (Cerebyx). 
Emergent head CT showed evolving infarct in the 
left parietal lobe but no new lesions [Figure 1]. On 
reexamination post-ictally, she exhibited worsening of her 
neurological deficits, with right hemiplegia and impaired 
comprehension, which persisted despite continued 
aggressive titration of hemodynamic therapy, including 
fluids and vasopressors. Her worsened expressive language 
deficits were more obvious after extubation on day 12. 
Head CT at that time showed a new large area of mixed 
hypo- and hyperdensity in the left anterior cerebral 
artery territory consistent with hemorrhagic infarction 
[Figure 2]. Vasopressor therapy was continued till day 14 
and then weaned off when no neurological improvement 
was observed. She required a gastrostomy tube for 
feeding due to persistent dysphagia. She was ultimately 
discharged to a rehabilitation facility on day 28, with 
no further seizures on AED therapy. When seen at the 
1-month follow-up, she had minimal speech output, a 
spastic right hemiparesis and cognitive deficits involving 
memory and attention.
DISCUSSION
The patient included in this case report received a brief 
(3-day) course of phenytoin for seizure prophylaxis, as 
was our usual practice. She developed clinical vasospasm 
that was stabilized with hemodynamic augmentation 
and her deficits had essentially resolved at the time that 
she experienced a seizure on day 10. She suffered re-
Figure 1: Head computed tomography (day 10) performed 
soon after her seizure, showing evolution of previously noted 
hypodensity in the left parietal region
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Figure 2: Head computed tomography (day 12) showing new area of infarction with hemorrhagic transformation noted in the left 
anterior cerebral artery territory
emergent neurological deficits likely related to worsening 
cerebral ischemia in the territories most affected by 
angiographic vasospasm. This eventually resulted in 
radiographic infarction and persistent disability despite 
maximal medical therapy.
Seizures increase cerebral metabolic demands and can 
cause neuronal injury.[3,8] In the setting of significant 
vasospasm, where cerebral oxygen and glucose delivery 
is already reduced, an increase in substrate demand 
could precipitate an acute metabolic crisis, resulting 
in ischemia. Any hypoxemia and/or hypotension (both 
seen in our case) that may accompany seizures or their 
management could also worsen oxygen delivery. The 
potential for seizures to exacerbate secondary brain injury 
and raise intracranial pressure has been highlighted in 
the setting of brain trauma.[9,10] A similar mechanism 
may be theorized to explain why an isolated seizure in 
our patient precipitated irreversible cerebral injury in the 
setting of vasospasm.
The optimal regimen for AED prophylaxis 
remains controversial with little to guide formal 
recommendations.[4] The potential for seizures to 
exacerbate delayed cerebral ischemia may influence the 
duration of seizure prophylaxis after SAH. Many have 
argued for a shorter course of AEDs after SAH, given the 
association between their use and worse outcomes.[5,7] 
Additionally, one retrospective study found no increase 
in seizure incidence when comparing a 3-day course 
of phenytoin to patients receiving longer durations of 
prophylaxis.[2] However, as in our case, seizures have 
been shown to occur in the period when delayed cerebral 
ischemia is a real concern.[6] Our case highlights the 
potential consequences of epileptic activity in this setting 
and adds an additional reason to consider a period of 
AED prophylaxis that extends at least 14 days (i.e., 
through the peak window of cerebral vasospasm) after 
SAH. Further studies are needed to better define the 
optimal length of seizure prophylaxis for this patient 
population.
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